Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship

Plasminogen activator inhibitor 1 (PAI-1) also known as serpin E1 or endothelial plasminogen activator inhibitor, is produced from endothelial cells and adipose tissue. PAI-1 inhibits tissue plasminogen activator (tPA) and urokinase (uPA) preventing activation of plasminogen and fibrinolysis. Gestat...

Descripción completa

Detalles Bibliográficos
Autores principales: Batiha, Gaber El-Saber, Al-kuraishy, Hayder M., Al-Maiahy, Thabat J., Al-Buhadily, Ali K., Saad, Hebatallah M., Al-Gareeb, Ali I., Simal-Gandara, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454110/
https://www.ncbi.nlm.nih.gov/pubmed/36076264
http://dx.doi.org/10.1186/s13098-022-00900-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454110/
https://www.ncbi.nlm.nih.gov/pubmed/36076264
http://dx.doi.org/10.1186/s13098-022-00900-2

Ejemplares similares